Cbd oil dosage for sleep
Pro Research Analysisby 
Searched over 200M research papers
CBD Oil Dosage for Sleep: Clinical Evidence and Recommendations
CBD Dosage Levels Studied for Sleep Improvement
Research on CBD oil for sleep has primarily focused on low to moderate daily doses. The most common dosages studied are 15 mg, 50 mg, and 150 mg of CBD taken orally, usually before bedtime. Some studies have also examined higher single doses, such as 200 mg or 300 mg, but these are less common in routine use for sleep issues Narayan2024Saleska2023Saleska2023+4 MORE.
Effects of 15 mg to 50 mg CBD on Sleep Quality
Multiple large-scale randomized controlled trials have shown that daily use of 15 mg CBD can lead to significant improvements in self-reported sleep quality for adults experiencing sleep disturbances. These improvements were similar to those seen with 5 mg melatonin, a well-known sleep aid. The addition of other cannabinoids like cannabinol (CBN) or cannabichromene (CBC) did not provide extra benefits over CBD alone. Importantly, these low doses were well tolerated, with only mild side effects reported in a small percentage of users Saleska2023Saleska2023.
A separate study in healthy young adults found that 50 mg of CBD daily for eight weeks improved sleep quality, as measured by sleep questionnaires, without affecting sleep quantity or causing significant side effects .
Effects of 150 mg CBD on Insomnia
Several clinical trials have tested 150 mg of CBD taken nightly for people with moderate to severe primary insomnia. These studies found that both CBD and placebo groups experienced reduced insomnia severity, but CBD did not outperform placebo in most sleep outcomes, such as sleep onset, sleep efficiency, or wake after sleep onset. However, participants taking CBD reported greater well-being and some improvements in objective sleep efficiency after two weeks. Cognitive performance was not affected, and the safety profile was favorable Narayan2024Narayan2022Narayan2024.
Higher Doses and Combination Formulations
Some studies have explored higher doses or combinations of CBD with THC (tetrahydrocannabinol). For example, a single dose of 200 mg CBD combined with 10 mg THC was found to reduce total sleep time and REM sleep in people with insomnia, but did not impair next-day cognitive performance. However, this combination also led to more mild side effects, such as dry mouth and drowsiness Suraev2020Suraev2022. In patients with systemic sclerosis, a cannabis oil containing both CBD and THC showed trends toward improved sleep, but results were not statistically significant .
A single 300 mg dose of CBD in healthy volunteers did not alter sleep architecture or the sleep-wake cycle, suggesting that acute high doses may not have a strong effect on sleep in people without sleep disorders .
Safety and Side Effects
Across all studies, CBD was generally well tolerated, with mild side effects such as dry mouth being the most common. No severe adverse events were reported at the dosages studied (15 mg to 200 mg daily) Narayan2024Saleska2023Saleska2023+4 MORE.
Conclusion
Clinical research suggests that low to moderate doses of CBD oil (15 mg to 150 mg taken nightly) are safe and may help improve sleep quality for some people, especially those with sleep disturbances or insomnia. However, the effects are often similar to placebo, and not all studies show a clear benefit over other sleep aids like melatonin. Higher doses or combinations with THC may have different effects and more side effects. More research is needed to determine the optimal dose and long-term safety for sleep improvement. If considering CBD oil for sleep, starting with a low dose and monitoring effects is recommended.
Sources and full results
Most relevant research papers on this topic
Cannabidiol for moderate–severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing
Nightly supplementation of 150 mg CBD was similar to placebo in most sleep outcomes while sustaining greater well-being, suggesting more prominent psychological effects.
Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial
The CANSLEEP trial will evaluate the effects of a single dose of an oral cannabis-based medicine on sleep and daytime function in participants with chronic insomnia disorder.
The safety and relative effectiveness of non-psychoactive cannabinoid formulations for the improvement of sleep: a double-blinded, randomized controlled trial
Chronic use of low doses of CBD is safe and can improve sleep quality, but effects do not exceed those of 5 mg melatonin, and the addition of minor cannabinoids may not enhance these effects.
DOI